Investors Sell Shares of UnitedHealth Group Inc. (UNH) on Strength (UNH)
Traders sold shares of UnitedHealth Group Inc. (NYSE:UNH) on strength during trading on Monday. $41.92 million flowed into the stock on the tick-up and $75.29 million flowed out of the stock on the tick-down, for a money net flow of $33.37 million out of the stock. Of all companies tracked, UnitedHealth Group had the 0th highest net out-flow for the day. UnitedHealth Group traded up $0.05 for the day and closed at $142.09
A number of research firms have weighed in on UNH. Jefferies Group reiterated a “buy” rating and issued a $153.00 target price on shares of UnitedHealth Group in a research note on Tuesday, May 17th. Morgan Stanley reiterated a “buy” rating on shares of UnitedHealth Group in a research note on Wednesday, May 18th. Credit Suisse Group AG reiterated a “buy” rating on shares of UnitedHealth Group in a research note on Wednesday, May 18th. Leerink Swann reiterated a “buy” rating on shares of UnitedHealth Group in a research note on Friday, June 10th. Finally, Sanford C. Bernstein began coverage on UnitedHealth Group in a research note on Wednesday, June 15th. They issued an “outperform” rating and a $171.00 target price on the stock. One investment analyst has rated the stock with a hold rating, twenty-four have given a buy rating and one has issued a strong buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus target price of $153.44.
The company has a market capitalization of $135.33 billion and a P/E ratio of 22.24. The firm’s 50-day moving average is $142.04 and its 200 day moving average is $132.33.
UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, July 19th. The healthcare conglomerate reported $1.96 earnings per share for the quarter, topping the consensus estimate of $1.89 by $0.07. The firm earned $46.50 billion during the quarter, compared to analysts’ expectations of $45.05 billion. On average, equities analysts predict that UnitedHealth Group Inc. will post $7.91 EPS for the current year.
The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 20th. Investors of record on Friday, September 9th will be given a $0.625 dividend. This represents a $2.50 annualized dividend and a dividend yield of 1.76%. The ex-dividend date of this dividend is Tuesday, September 6th.
In related news, Director Gail R. Wilensky sold 5,500 shares of the stock in a transaction on Friday, June 10th. The stock was sold at an average price of $139.80, for a total value of $768,900.00. Following the transaction, the director now directly owns 59,019 shares of the company’s stock, valued at approximately $8,250,856.20. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director William C. Ballard, Jr. sold 5,000 shares of the stock in a transaction on Thursday, June 16th. The stock was sold at an average price of $138.58, for a total value of $692,900.00. Following the completion of the transaction, the director now directly owns 72,229 shares in the company, valued at $10,009,494.82. The disclosure for this sale can be found here.
Several hedge funds and institutional investors have recently modified their holdings of the company. Nelson Van Denburg & Campbell Wealth Management Group LLC raised its position in shares of UnitedHealth Group by 2.6% in the fourth quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC now owns 10,013 shares of the healthcare conglomerate’s stock valued at $1,178,000 after buying an additional 255 shares during the period. Argent Trust Co raised its position in UnitedHealth Group by 0.5% in the third quarter. Argent Trust Co now owns 13,437 shares of the healthcare conglomerate’s stock valued at $1,559,000 after buying an additional 65 shares during the period. King Luther Capital Management Corp raised its position in UnitedHealth Group by 23.4% in the fourth quarter. King Luther Capital Management Corp now owns 15,723 shares of the healthcare conglomerate’s stock valued at $1,850,000 after buying an additional 2,978 shares during the period. Victory Capital Management Inc. raised its position in UnitedHealth Group by 224.8% in the fourth quarter. Victory Capital Management Inc. now owns 18,755 shares of the healthcare conglomerate’s stock valued at $2,206,000 after buying an additional 12,981 shares during the period. Finally, Airain ltd bought a new position in UnitedHealth Group during the fourth quarter valued at approximately $2,209,000.
UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.